Ptc Therapeutics (PTCT) Cash & Equivalents Growth (1y) (2013 - 2026)
Ptc Therapeutics (PTCT) Cash & Equivalents Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
988.88% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
3.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.77% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ptc Therapeutics |
6.51 Bn |
4.61 Bn |
244.52 Mn |
-43.66% |
| Date | Value |
|---|
| Mar 31, 2026 |
-43.66% |
| Dec 31, 2025 |
26.28% |
| Sep 30, 2025 |
27.87% |
| Jun 30, 2025 |
55.38% |
| Mar 31, 2025 |
169.94% |
| Dec 31, 2024 |
31.26% |
| Sep 30, 2024 |
218.49% |
| Jun 30, 2024 |
214.20% |
| Mar 31, 2024 |
227.39% |
| Dec 31, 2023 |
112.27% |
| Sep 30, 2023 |
58.16% |
| Jun 30, 2023 |
31.76% |
| Mar 31, 2023 |
16.17% |
| Dec 31, 2022 |
47.50% |
| Sep 30, 2022 |
-44.99% |
| Jun 30, 2022 |
-10.82% |
| Mar 31, 2022 |
-1.67% |
| Dec 31, 2021 |
-9.14% |
| Sep 30, 2021 |
-56.26% |
| Jun 30, 2021 |
11.92% |
